logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bernhard Scheiner

Medical University of Vienna
H指数:43
被引数:7,638

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood- and Liver Stiffness-Based Non-Invasive Tests for Clinically Significant Portal Hypertension in Patients With cACLD and HCC

基于血液和肝脏硬度检测的无创性检查在慢性肝纤维化相关肝硬化及肝癌患者中临床显著门静脉高压的诊断应用

Liver International
IF5.2
2026-10-280
OAAI
Lorenz Balcar; Tina Jasmin Haunold; Mathias Jachs; Georg Semmler; Benedikt Simbrunner; Albert Friedrich Stättermayer; David Pereyra; Christoph Schwarz; Stefan Stremitzer; Klaus Kaczirek; Patrick Starlinger; Peter Quehenberger; Michael Trauner; Bernhard Scheiner; Thomas Reiberger; Matthias Pinter; Mattias Mandorfer
ALBI ‐6—A Novel Prognostic Score Combining ALBI and Interleukin‐6 in Patients With HCC Treated With Atezolizumab and Bevacizumab

ALBI‐6——一种结合ALBI和白细胞介素‐6的新型预后评分，用于接受阿替利珠单抗和贝伐珠单抗治疗的HCC患者

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2026-10-080
OAAI
Paula Bark; Lucas Wiesmann; Simon Johannes Gairing; Kateryna Shmanko; Lukas Müller; Maximilian Moos; Fabian Stöhr; Dirk Graafen; Tilman Emrich; Felix Hahn; Daniel Pinto dos Santos; Bernhard Scheiner; Victoria Berit Berger; Matthias Pinter; Valentina Zarka; Florian P. Reiter; Andreas Geier; Najib Ben Khaled; Alexander Philipp; Christoph Springfeld; Aurelie Tomczak; Michael T. Dill; Constantin Scholz; Jens Mittler; Hauke Lang; Beate Katharina Straub; Roman Kloeckner; Tobias Bäuerle; Christian Markus Lange; Arndt Weinmann; Peter Robert Galle; Friedrich Foerster
FMT combined with atezolizumab-bevacizumab in hepatocellular carcinoma refractory to immunotherapy: an open label, single-arm, phase II pilot study

FMT联合阿替利珠单抗-贝伐珠单抗在免疫治疗耐药的肝细胞癌中的应用：一项开放标签、单臂、II期初步研究

Nature Communications
IF15.7
2026-10-070
OA
Katharina Pomej; Adrian Frick; Bernhard Scheiner; Maximilian Baumgartner; Klaus G. Schmetterer; Carlos S. Reyna-Blanco; Lorenz Balcar; Larissa Pajancic; Abelina Kreuter; Joana Séneca; Bela Hausmann; Thomas Köcher; Melanie Prinzensteiner; Katharina Lampichler; Nataliya Rohr-Udilova; Adrija Chakrabarty; Anton Klotz; Annika C. Lampl; Kerstin Zinober; Katharina Regnat; Michael Trauner; David Berry; Dietmar Tamandl; Thomas Vogl; Christoph Gasche; Matthias Pinter
CAPTYN, a Blood-Based Machine Learning Model Predicting Clinical Benefit of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: Validation in IMbrave150 Trial

CAPTYN，一种基于血液的机器学习模型预测阿替利珠单抗–贝伐珠单抗在肝细胞癌中的临床获益：IMbrave150试验中的验证

Cancer Communications
IF24.9
2026-09-290
OA
Gae Hoon Jo; Sohyun Hwang; Bernhard Scheiner; Seonjeong Woo; Won Suk Lee; Beodeul Kang; Jung Sun Kim; Ho Yeong Lim; Chansik An; Dong Yun Kim; Inyoung Kim; Dong-hyuk Heo; Matthias Pinter; Beom Kyung Kim; Chan Kim; Hong Jae Chon
Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk (vol 19, 101932, 2026)

酒精摄入重编程肝免疫-代谢回路以加剧小鼠动脉粥样硬化和人类心血管风险（vol 19, 101932, 2026）

JHEP Reports
IF7.5
2026-09-010
OA
Hoebinger, Constanze; Semmler, Georg; Petrenko, Oleksandr; Rajcic, Dragana; Hoffelner, Dorothea Katharina; Duckova, Tereza; Baranovskyi, Taras; Goederle, Laura; Khuu, My Phung; Paeslack, Nadja; Reinhardt, Christoph; Pjevac, Petra; Seneca, Joana; Mieczkowski, Kamil; Burger, Katharina; Bergheim, Ina; Gensluckner, Sophie; Volkerer, Andreas; Reiberger, Thomas; Scheiner, Bernhard; Aigner, Elmar; Wernly, Bernhard; Datz, Christian; Binder, Christoph J.; Hendrikx, Tim
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma—Data From the Multinational LITCHI Registry

免疫检查点抑制剂治疗后肝细胞癌患者的肝移植——来自跨国LITCHI登记研究的数据

Liver International
IF5.2
2026-05-190
OAAI
Ulrike Bauer; Maria R. Troppmair; Najib Ben Khaled; Julia M. Grottenthaler; Friedrich Foerster; Sena Blümel; Sophia Heinrich; Friedrich Sinner; Matthias Pinter; Magdalena Hahn; Florian van Bömmel; Bernhard Scheiner; Marino Venerito; Richard Taubert; Andreas E. Kremer; Arndt Weinmann; Christoph P. Berg; Christian M. Lange; Enrico N. De Toni; Angela Djanani; Heinz Zoller; Roland M. Schmid; Ursula Ehmer
Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma

不可切除肝细胞癌患者接受阿替利珠单抗联合贝伐珠单抗长期生存的影响因素

European Journal of Cancer
IF7.1
2026-04-160
PRE
Pei-Chang Lee; Alessio Cortellini; Bernardo Stefanini; Changhoon Yoo; Hong Jae Chon; Jaekyung Cheon; Masatoshi Kudo; Naoshi Nishida; Bernhard Scheiner; Matthias Pinter; Pasquale Lombardi; Claudia Angela Maria Fulgenzi; Antonio D'Alessio; Leonardo Brunetti; Aria Torkpour; Elena Valenzi; Fionnuala Crowley; Thomas U Marron; Wei-Fan Hsu; Ciro Celsa
Radiomics-Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans

基于放射组学的门静脉高压严重程度评估及肝硬化患者风险分层：使用常规CT扫描

Liver International
IF5.2
2026-04-060
OAAI
Celine Sin; Martin Luther Watzenboeck; Eugenia Iofinova; Lorenz Balcar; Georg Semmler; Bernhard Scheiner; Katharina Lampichler; Mattias Mandorfer; Lucile Moga; Pierre-Emmanuel Rautou; Maxime Ronot; Jörg Menche; Thomas Reiberger; Martina Scharitzer
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: results of the DT-real study

在临床实践中，durvalumab联合或单药使用tremelimumab治疗肝细胞癌的可重复安全性及有效性：DT-real研究结果

JHEP Reports
IF7.5
2025-11-200
OAAI
Ciro Celsa; Tiziana Pressiani; Naoshi Nishida; Shadi Mohamad Chamseddine; Ashwini Arvind; Michael Li; Marta Fortuny; Najib Ben Khaled; Massimo Iavarone; Hidenori Toyoda; Ilario Giovanni Rapposelli; Andrea Casadei-Gardini; Caterina Vivaldi; Susanna Ulahannan; Haripriya Andanamala; Bernhard Scheiner; Matthias Pinter; Elena Orlandi; Claudia A.M. Fulgenzi; Giulia F. Manfredi
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

细胞外基质重塑的生物标志物与晚期慢性肝病的严重程度和预后相关

Alimentary Pharmacology & Therapeutics
IF6.7
2025-10-120
OAAI
Benedikt Simbrunner; Ida Falk Villesen; Georg Semmler; Lorenz Balcar; Georg Kramer; Joana Almeida Calvão; Benedikt Silvester Hofer; Mathias Jachs; Lukas Hartl; Jurij Maurer; Bernhard Scheiner; Kerstin Zinober; Rodrig Marculescu; Michael Trauner; Morten Karsdal; Thomas Reiberger; Mattias Mandorfer; Diana Julie Leeming
Lenvatinib versus sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: the LEVIATHAN Study

伦伐替尼对比索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌的二线治疗：LEVIATHAN 研究

JHEP Reports
IF7.5
2025-09-230
OAAI
Pasquale Lombardi; Jung Sun Kim; Giulia F. Manfredi; Ciro Celsa; Claudia A.M. Fulgenzi; Antonio D’Alessio; Bernardo Stefanini; Niraj C. Doshi; Emily Warmington; Thomas U. Marron; Matthias Pinter; Bernhard Scheiner; Beodeul Kang; Ho Yeong Lim; Wei-Fan Hsu; Brooke Wietharn; Marianna Silletta; Alessandro Parisi; Chun-Yen Lin; Andrea Dalbeni; Gianluca Masi; Martin Schönlein; Johann von Felden; Fabio Piscaglia; Peter R. Galle; Masatoshi Kudo; Tiziana Pressiani; Lorenza Rimassa; Mario Pirisi; Giuseppe Cabibbo; Hong Jae Chon; David J. Pinato
Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study

研究方案：粪菌移植联合Atezolizumab/Bevacizumab在未能达到或维持对Atezolizumab/Bevacizumab客观反应的肝细胞癌患者中的应用——FAB-HCC探索性研究

PLOS ONE
IF2.6
2025-04-150
OA
Pomej, Katharina; Frick, Adrian; Scheiner, Bernhard; Balcar, Lorenz; Pajancic, Larissa; Klotz, Anton; Kreuter, Abelina; Lampichler, Katharina; Regnat, Katharina; Zinober, Kerstin; Trauner, Michael; Tamandl, Dietmar; Gasche, Christoph
Outcomes of durvalumab with or without tremelimumab in routine clinical practice according to HIMALAYA Trial Eligibility: preliminary results of the international DT-real study
DIGESTIVE AND LIVER DISEASE
IF3.8
2025-02-010
PRE
Celsa, C.; Nishida, N.; Chamseddine, S. M.; Arvind, A.; Li, M.; Toyoda, H.; Ulahannan, S.; Fulgenzi, C. A. M.; Manfredi, G. F.; D'Alessio, A.; Stefanini, B.; Cabibbo, G.; Camma, C.; Scheiner, B.; Rimassa, L.; Kelley, R. K.; Singal, A. G.; Kaseb, A. O.; Kudo, M.; Pinato, D. J.
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)

在联合免疫治疗和靶向治疗后，纵向身体组成可识别恶病质的肝细胞癌 (CHANCE2213)

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
IF9.1
2024-11-270
OA
Jin, Zhi-Cheng; Zhou, Jia-Wei; Chen, Jian-Jian; Ding, Rong; Scheiner, Bernhard; Wang, Si-Na; Li, Hai-Liang; Shen, Qing-Xia; Lu, Qing-Yun; Liu, Yi; Zhang, Wei-Hua; Luo, Biao; Shi, Hai-Bin; Huang, Ming; Wu, Ye-Ming; Yuan, Chun-Wang; Huang, Ming-Sheng; Li, Jia-Ping; Wu, Jian-Bing; Zhu, Xiao-Li; Zhong, Bin-Yan; Zhou, Hai-Feng; Wang, Yu-Qing; Gu, Shan-Zhi; Peng, Zhi-Yi; Zheng, Chuan-Sheng; Liu, Rui-Bao; Xu, Guo-Hui; Yang, Wei-Zhu; Xu, Ai-Bing; Liu, Dong-Fang; Qi, Xiaolong; Yeo, Yee Hui; Zhu, Hai-Dong; Zhao, Yang; Pinato, David J.; Ji, Fanpu; Teng, Gao-Jun
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy
HEPATOLOGY
IF15.8
2024-11-211
PRE
Scheiner, Bernhard; Kang, Beodeul; Balcar, Lorenz; Radu, Iuliana-Pompilia; Reiter, Florian P.; Adzic, Gordan; Guo, Jiang; Gao, Xu; Yuan, Xiao; Cheng, Long; Gorgulho, Joao; Schultheiss, Michael; Peeters, Frederik; Hucke, Florian; Ben Khaled, Najib; Piseddu, Ignazio; Philipp, Alexander; Sinner, Friedrich; D'Alessio, Antonio; Pomej, Katharina; Saborowski, Anna; Bathon, Melanie; Schwacha-Eipper, Birgit; Zarka, Valentina; Lampichler, Katharina; Nishida, Naoshi; Lee, Pei-Chang; Krall, Anja; Saeed, Anwaar; Himmelsbach, Vera; Tesini, Giulia; Huang, Yi-Hsiang; Vivaldi, Caterina; Masi, Gianluca; Vogel, Arndt; Schulze, Kornelius; Trauner, Michael; Djanani, Angela; Stauber, Rudolf; Kudo, Masatoshi; Parikh, Neehar D.; Dufour, Jean-Francois; Prejac, Juraj; Geier, Andreas; Bengsch, Bertram; von Felden, Johann; Venerito, Marino; Weinmann, Arndt; Peck-Radosavljevic, Markus; Finkelmeier, Fabian; Dekervel, Jeroen; Ji, Fanpu; Wang, Hung-Wei; Rimassa, Lorenza; Pinato, David J.; Bouattour, Mohamed; Chon, Hong Jae; Pinter, Matthias

研究方向

暂未获取到该数据
T
Thomas Reiberger
H 指数:72论文数:1,098被引数:2.2万
M
Michael Trauner
H 指数:128论文数:3,382被引数:6.7万
M
Mattias Mandorfer
H 指数:57论文数:794被引数:1.4万
M
Matthias Pinter
H 指数:55论文数:461被引数:1.1万
B
Benedikt Simbrunner
H 指数:32论文数:290被引数:3,392
G
Georg Semmler
H 指数:36论文数:392被引数:4,134
L
Lorenz Balcar
H 指数:27论文数:330被引数:2,888
P
Philipp Schwabl
H 指数:42论文数:289被引数:8,155
D
David Bauer
H 指数:35论文数:198被引数:3,701
R
Rafael Paternostro
H 指数:32论文数:145被引数:3,341